WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6 million, or $0.57 per share, compared with a net loss of $4.1 million, or $0.20 per share, in the same period of 2008. As of September 30, 2009, Safeguard had $131 million of cash, excluding cash held in escrow, to pursue its operating activities, including the support of existing partner companies, and to deploy capital in new, exciting, high-potential growth life sciences and technology companies.
